Clincal interpretation of the anti-tuberculosis drug concentrations in diabetic and non-diabetic tuberculosis patients

被引：0
作者：
Nilan T Jacob
机构：
[1] Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER),
来源：
European Journal of Clinical Pharmacology | 2017年 / 73卷
关键词：
Isoniazid; Tuberculosis Patient; Plasma Drug Concentration; Pyrazinamide; Elevated Blood Glucose;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1049 / 1049
相关论文
共 9 条
  • [1] Hemanth Kumar AK(2017)Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus Euro J Clin Pharmacol 73 65-70
  • [2] Chandrasekaran V(2011)The impact of diabetes on tuberculosis treatment outcomes: a systematic review BMC Med 9 81-S16
  • [3] Kannan T(2015)undefined Diabetes Care 38 S8-3619
  • [4] Baker MA(2013)undefined Antimicrob Agents Chemother 57 3614-undefined
  • [5] Harries AD(undefined)undefined undefined undefined undefined-undefined
  • [6] Jeon CY(undefined)undefined undefined undefined undefined-undefined
  • [7] Burhan E(undefined)undefined undefined undefined undefined-undefined
  • [8] Ruesen C(undefined)undefined undefined undefined undefined-undefined
  • [9] Ruslami R(undefined)undefined undefined undefined undefined-undefined
1